Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use OMVOH safely and effectively. See full prescribing information for OMVOH. OMVOH (mirikizumab-mrkz) injection, for intravenous or subcutaneous useInitial U.S. Approval: 2023
Medication labelWhy this: Advisory · dailymed-prescription
OMVOH is indicated for the treatment of: moderately to severely active ulcerative colitis in adults. moderately to severely active Crohn's disease in adults.
- generic_name
- mirikizumab-mrkz
- product_names
- mirikizumab-mrkz
- ndc
- 0002-7575, 0002-7575-01, 0002-8011, 0002-8011-01, 0002-8011-27, 0002-8011-61, 0002-8011-02, 0002-8870, 0002-8870-01, 0002-8870-27, 0002-7717, 0002-7717-11, 0002-7717-61, 0002-3116, 0002-3116-01, 0002-7722, 0002-7722-11, 0002-1442, 0002-1442-01, 0002-3116-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en